Bifogade filer
PDF
Kurs
+2,43%
Likviditet
0,11 MSEK
Kalender
| Tid* | ||
| 2024-02-21 | - | Bokslutskommuniké 2023 |
| 2023-11-13 | - | Extra Bolagsstämma 2023 |
| 2023-11-09 | - | Kvartalsrapport 2023-Q3 |
| 2023-08-04 | - | Kvartalsrapport 2023-Q2 |
| 2023-07-03 | - | X-dag ordinarie utdelning IRRAS 0.00 SEK |
| 2023-06-30 | - | Årsstämma |
| 2023-05-17 | - | Kvartalsrapport 2023-Q1 |
| 2023-02-16 | - | Bokslutskommuniké 2022 |
| 2022-11-10 | - | Kvartalsrapport 2022-Q3 |
| 2022-07-22 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-25 | - | X-dag ordinarie utdelning IRRAS 0.00 SEK |
| 2022-05-24 | - | Årsstämma |
| 2022-04-27 | - | Kvartalsrapport 2022-Q1 |
| 2022-02-16 | - | Bokslutskommuniké 2021 |
| 2021-11-09 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-26 | - | Kvartalsrapport 2021-Q2 |
| 2021-07-15 | - | Extra Bolagsstämma 2021 |
| 2021-05-04 | - | Kvartalsrapport 2021-Q1 |
| 2021-04-29 | - | X-dag ordinarie utdelning IRRAS 0.00 SEK |
| 2021-04-28 | - | Årsstämma |
| 2021-02-16 | - | Bokslutskommuniké 2020 |
| 2020-11-10 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-27 | - | Kvartalsrapport 2020-Q2 |
| 2020-05-14 | - | Kvartalsrapport 2020-Q1 |
| 2020-04-29 | - | X-dag ordinarie utdelning IRRAS 0.00 SEK |
| 2020-04-28 | - | Årsstämma |
| 2020-03-02 | - | Extra Bolagsstämma 2020 |
| 2020-02-14 | - | Bokslutskommuniké 2019 |
| 2019-11-08 | - | Kvartalsrapport 2019-Q3 |
| 2019-08-29 | - | Kvartalsrapport 2019-Q2 |
| 2019-05-15 | - | Kvartalsrapport 2019-Q1 |
| 2019-05-15 | - | X-dag ordinarie utdelning IRRAS 0.00 SEK |
| 2019-05-14 | - | Årsstämma |
| 2019-02-14 | - | Bokslutskommuniké 2018 |
| 2018-11-07 | - | Kvartalsrapport 2018-Q3 |
| 2018-08-27 | - | Kvartalsrapport 2018-Q2 |
| 2018-06-04 | - | X-dag ordinarie utdelning IRRAS 0.00 SEK |
| 2018-05-29 | - | Kvartalsrapport 2018-Q1 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | Small Cap Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
2023-10-15
Stockholm, Sweden (October 15, 2023) - IRRAS AB (publ) ("IRRAS" or the "Company") today announced an extension of its SEK 20 million short-term loan from IR Holding Bidco Inc. ("IR Holding"). The loan will continue to carry an interest rate in the amount of 6.00% on an annual basis.
Under this extension, the loan will now fall due on 31 December 2023. Repayment of the loan will continue to be secured by a pledge over the company's patents and the shares of the company's United States subsidiary, IRRAS USA Inc. In addition, IRRAS USA Inc. have guaranteed all obligations of IRRAS AB under the loan agreement, and IRRAS AB have entered into a license agreement with IRRAS USA Inc. (which such agreement being collaterally assigned to the lender) under which IRRAS AB grants IRRAS USA Inc. an exclusive, royalty-free, fully-paid, irrevocable, perpetual license to all of IRRAS's intellectual property everywhere in the world other than Sweden, Denmark Norway and Finland.